Patents by Inventor Byoung Heon Kang

Byoung Heon Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR INHIBITING NEOVASCULARIZATION FACTORS AND USE THEREOF
    Publication number: 20230088747
    Abstract: The present specification relates to compounds for inhibiting neovascularization factors and use thereof. Furthermore, the present specification relates to methods for treating neovascularization diseases using the compounds.
    Type: Application
    Filed: December 16, 2020
    Publication date: March 23, 2023
    Inventors: Byoung Heon Kang, So-Yeon Kim, Nam Gu Yoon, Changwook Lee, Dong Ho Park
  • Mitochondria-targeted anti-tumor agents
    Patent number: 9987294
    Abstract: Described are mitochondria-targeted anti-tumor agents, and methods of making and using the same for the treatment of disorders associated with unwanted cell proliferation.
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: June 5, 2018
    Assignee: University of Massachusetts
    Inventors: Dario C. Altieri, Byoung Heon Kang
  • MITOCHONDRIA-TARGETED ANTI-TUMOR AGENTS
    Publication number: 20160184333
    Abstract: Described are mitochondria-targeted anti-tumor agents, and methods of making and using the same for the treatment of disorders associated with unwanted cell proliferation.
    Type: Application
    Filed: March 15, 2016
    Publication date: June 30, 2016
    Inventors: Dario C. Altieri, Byoung Heon Kang
  • MITOCHONDRIA-TARGETED ANTI-TUMOR AGENTS
    Publication number: 20140142121
    Abstract: Described are mitochondria-targeted anti-tumor agents, and methods of making and using the same for the treatment of disorders associated with unwanted cell proliferation.
    Type: Application
    Filed: May 29, 2013
    Publication date: May 22, 2014
    Inventors: Dario C. Altieri, Byoung Heon Kang
  • Mitochondria-targeted anti-tumor agents
    Patent number: 8466140
    Abstract: Described are mitochondria-targeted anti-tumor agents, and methods of making and using the same for the treatment of disorders associated with unwanted cell proliferation.
    Type: Grant
    Filed: September 10, 2008
    Date of Patent: June 18, 2013
    Assignee: University of Massachusetts
    Inventors: Dario C. Altieri, Byoung Heon Kang
  • MITOCHONDRIA-TARGETED ANTI-TUMOR AGENTS
    Publication number: 20090099080
    Abstract: Described are mitochondria-targeted anti-tumor agents, and methods of making and using the same for the treatment of disorders associated with unwanted cell proliferation.
    Type: Application
    Filed: September 10, 2008
    Publication date: April 16, 2009
    Inventors: Dario C. Altieri, Byoung Heon Kang